Wednesday, March 27, 2019

Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment

A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis.

from Top Health News -- ScienceDaily https://ift.tt/2JGXz5y
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

One tiny mutation may explain how bat viruses become human threats

Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with...